ORIC - ORIC Pharmaceuticals Inc
12.59
0 0%
Share volume: 1,348,724
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$12.59
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-06-2024 | 08-12-2024 | 11-12-2024 | 02-18-2025 | 05-05-2025 | 11-13-2025 | 02-23-2026 | |
| Assets | ||||||||
| Total Assets | 350.786 M | 328.906 M | 302.070 M | 274.142 M | 242.858 M | 431.192 M | 408.890 M | |
| Current Assets | 324.083 M | 294.599 M | 279.428 M | 262.250 M | 211.433 M | 295.594 M | 288.466 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 260.418 M | 236.575 M | 228.139 M | 196.554 M | 154.389 M | 237.472 M | 235.819 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 56.360 M | 49.831 M | 44.230 M | 59.406 M | 49.334 M | 49.668 M | 45.669 M | |
| Total Non-current Assets | 14.694 M | 22.126 M | 9.998 M | 0.000 | 20.039 M | 125.908 M | 110.762 M | |
| Property Plant Equipment | 2.801 M | 2.878 M | 3.091 M | 2.924 M | 3.021 M | 2.559 M | 2.415 M | |
| Other Assets | 23.902 M | 31.429 M | 19.551 M | 8.968 M | 28.404 M | 133.039 M | 118.009 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 350.786 M | 328.906 M | 302.070 M | 274.142 M | 242.858 M | 431.192 M | 408.890 M | |
| Total liabilities | 22.141 M | 26.506 M | 28.076 M | 31.020 M | 23.120 M | 24.273 M | 24.528 M | |
| Total current liabilities | 15.210 M | 19.539 M | 21.248 M | 24.846 M | 17.617 M | 20.179 M | 20.417 M | |
| Accounts Payable | 2.988 M | 2.309 M | 4.249 M | 1.548 M | 5.160 M | 2.900 M | 3.824 M | |
| Other liabilities | 6.931 M | 6.967 M | 6.828 M | 6.174 M | 5.503 M | 4.094 M | 4.111 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 6.931 M | 6.967 M | 6.828 M | 6.174 M | 5.503 M | 4.094 M | 4.111 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 328.645 M | 302.400 M | 273.994 M | 243.122 M | 219.738 M | 406.919 M | 384.362 M | |
| Common stock | 788.745 M | 794.557 M | 799.739 M | 805.517 M | 812.324 M | 1.068 B | 1.076 B | |
| Retained earnings | -459.938 M | -491.901 M | -526.467 M | -562.774 M | -592.795 M | -661.737 M | -692.242 M |